Literature DB >> 2965694

Protease-inhibitory activities of leupeptin analogues.

T Saino1, T Someno, S Ishii, T Aoyagi, H Umezawa.   

Abstract

Thirty analogues of leupeptin were synthesized and examined for their inhibitory activities against trypsin, papain, plasmin, kallikrein, thrombin and urokinase in vitro. Benzoyl- and alpha-naphthalenesulfonyl-L-leucyl-L-argininal were 8 times more inhibitory to papain, benzyloxycarbonyl-L-pyroglutamyl-L-leucyl-L-argininal 10 times more to trypsin and plasmin, and DL-2-pipecolyl-L-leucyl-L-argininal 25 times more to kallikrein than leupeptin. Against urokinase, only L-pyroglutamyl-L-leucyl-L-argininal exhibited a potent inhibitory activity. alpha-Naphthalensulfonyl-, dansyl- and benzyloxycarbonyl-(2S,3R)-3-amino-2-hydroxy-4-phenylbutyryl-L-leucyl-L- argininal were inhibitory to thrombin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2965694     DOI: 10.7164/antibiotics.41.220

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  4 in total

Review 1.  Microbial inhibitors of cysteine proteases.

Authors:  Mateusz Kędzior; Rafał Seredyński; Jan Gutowicz
Journal:  Med Microbiol Immunol       Date:  2016-04-05       Impact factor: 3.402

2.  Synthesis and Biological Activity of N-Sulfonyltripeptides with C-Terminal Arginine as Potential Serine Proteases Inhibitors.

Authors:  Agnieszka Markowska; Magdalena Bruzgo; Ewa Gorodkiewicz; Arkadiusz Surażyński
Journal:  Int J Pept Res Ther       Date:  2012-12-02       Impact factor: 1.931

3.  Thrombin alters the synthesis and processing of CYR61/CCN1 in human corneal stromal fibroblasts and myofibroblasts through multiple distinct mechanisms.

Authors:  Emily A Andreae; Debra J Warejcka; Sally S Twining
Journal:  Mol Vis       Date:  2020-07-29       Impact factor: 2.367

4.  Inhibition properties of free and conjugated leupeptin analogues.

Authors:  Erika Billinger; Johan Viljanen; Sara Bergström Lind; Gunnar Johansson
Journal:  FEBS Open Bio       Date:  2020-11-02       Impact factor: 2.693

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.